Chemosensory Receptor Screening via Venus Flytrap Domain Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need in the field to identify compounds or entities that can modify chemosensory receptors and their ligands to modulate chemosensory-related sensations or reactions, and to develop methods for screening such modifiers.

Innovation Solution

The method involves targeting the Venus flytrap domain of chemosensory receptors, specifically interacting sites within this domain, to identify and screen for candidates that can interact with chemosensory receptors or their ligands, using a combination of computer modeling and biological assays to determine suitable interacting residues and spaces for modulating receptor activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional screening methods are used to identify chemosensory receptor modifiers, then the process is simpler and faster, but the precision and reliability of identifying effective modifiers is insufficient

Engineering Contradiction:
Improveprecision of identifying receptor modifiersVSAvoidcomplexity of screening process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the chemosensory receptor into specific functional domains (Venus flytrap domain, transmembrane domains, intracellular domains) and identifies key interacting residues within each domain. This segmentation allows for targeted screening approaches that focus on specific regions rather than the entire receptor, improving precision while managing complexity through focused analysis of critical domains.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs computer modeling to create virtual copies and representations of the chemosensory receptor structure, including homology models and molecular dynamics simulations. These computational models serve as proxies for physical screening, enabling high-precision identification of potential modifiers through in silico screening before proceeding to experimental validation, thus improving precision without proportionally increasing overall process complexity.

Inventive Principle:
Principle #26Copying

2Reliability

If comprehensive biological assays are conducted to screen for receptor modifiers, then the reliability of results improves, but the time and resources required increase

Engineering Contradiction:
Improvereliability of modifier identificationVSAvoidtime for screening process
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent performs preliminary computational analysis including homology modeling, molecular docking, and molecular dynamics simulations to pre-identify promising candidate modifiers and their interacting residues. This preliminary action filters the candidate pool before experimental testing, ensuring that comprehensive biological assays are applied only to the most promising candidates, thereby maintaining high reliability while reducing overall screening time and resource requirements.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements a feedback loop where computational predictions guide experimental assays, and experimental results refine computational models. This iterative feedback process continuously improves the reliability of modifier identification by validating and refining predictions, while the feedback mechanism prevents unnecessary extensive screening of low-probability candidates, optimizing the time investment.

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If the entire chemosensory receptor is targeted for screening, then all potential binding sites are covered, but the complexity and computational requirements increase significantly

Engineering Contradiction:
Improvecoverage of binding sitesVSAvoidcomplexity of screening system
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies local quality by focusing screening efforts on specific functional domains with known or predicted ligand-binding capabilities, such as the Venus flytrap domain for sweet/umami taste receptors. Rather than uniformly screening the entire receptor structure, the method concentrates computational and experimental resources on regions with higher probability of containing active binding sites, maintaining comprehensive coverage of functional areas while reducing overall system complexity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent utilizes parameter changes by varying computational conditions (e.g., different docking algorithms, force fields, simulation temperatures) and experimental parameters (e.g., ligand concentrations, assay conditions) to optimize the detection of modifiers across different binding sites. This approach allows adaptable screening that can be tuned to target specific domains or residues, providing versatile coverage without requiring equally complex systems for all regions.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9603848B2Modulation of chemosensory receptors and ligands associated therewith
Publication Date: 2017.03.28 FIRMENICH INC
  • US9603848B2 patent drawing
  • US9603848B2 patent drawing
  • US9603848B2 patent drawing

AI summary

The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands.